The SkinGun has been waiting on that FDA approval for years.
Read more
Category: biotech/medical – Page 2529
Fight aging is a site that is highly focused on radical life extension medicine and science. They have a forecast that within five years the first meaningful life extension treatments will exist.
Senescent cell clearing overseas within five years for $5K-25K .
Read more
It’s the year 2021. A quadriplegic patient has just had one million “neural lace” microparticles injected into her brain, the world’s first human with an internet communication system using a wireless implanted brain-mind interface — and empowering her as the first superhuman cyborg. …
No, this is not a science-fiction movie plot. It’s the actual first public step — just four years from now — in Tesla CEO Elon Musk’s business plan for his latest new venture, Neuralink. It’s now explained for the first time on Tim Urban’s WaitButWhy blog.
Read more
Artificial intelligence algorithms are being taught to generate art, human voices, and even fiction stories all on their own—why not give them a shot at building new ways to treat disease?
Atomwise, a San Francisco-based startup and Y Combinator alum, has built a system it calls AtomNet (pdf), which attempts to generate potential drugs for diseases like Ebola and multiple sclerosis. The company has invited academic and non-profit researchers from around the country to detail which diseases they’re trying to generate treatments for, so AtomNet can take a shot. The academic labs will receive 72 different drugs that the neural network has found to have the highest probability of interacting with the disease, based on the molecular data it’s seen.
Atomwise’s system only generates potential drugs—the compounds created by the neural network aren’t guaranteed to be safe, and need to go through the same drug trials and safety checks as anything else on the market. The company believes that the speed at which it can generate trial-ready drugs based on previous safe molecular interactions is what sets it apart.
Read more
Tesla founder and chief executive Elon Musk said his latest company Neuralink is working to link the human brain with computers by creating micron-sized devices.
Neuralink is aiming to bring to the market a product that helps with certain severe brain injuries due to stroke and cancer lesion in about four years, Musk said in an interview with the website Wait But Why on Thursday.
“If I were to communicate a concept to you, you would essentially engage in consensual telepathy,” Musk said in the interview. Neuralink will be Musk’s third company along with Tesla and SpaceX.
Read more
Primarily talking about CRISPR.
Daisy Robinton explores bioengineering and its potential to end ageing.
“The use of gene-editing technology paired with the dropping cost of genome sequencing and analysis is greatly facilitating our ability to understand the functional and mechanistic impact of those genetic mutations on diseases caused by mutations in DNA sequence,” she says.
ABOUT WIRED HEALTH 2017
Hundreds of healthcare, pharmaceutical and technology influencers and leaders met at the fifth annual WIRED Health event at 30 Euston Square, London on March 9. Discover some of the fascinating insights from the esteemed speakers here: http://wired.uk/O6xMxJ
ABOUT WIRED EVENTS
WIRED events shine a spotlight on the innovators, inventors and entrepreneurs who are changing our world for the better. Explore this channel for videos showing on-stage talks, behind-the-scenes action, exclusive interviews and performances from our roster of events. Join us as we uncover the most relevant, up-and-coming trends and meet the people building the future.
ABOUT WIRED
WIRED brings you the future as it happens — the people, the trends, the big ideas that will change our lives. An award-winning printed monthly and online publication. WIRED is an agenda-setting magazine offering brain food on a wide range of topics, from science, technology and business to pop-culture and politics.
CONNECT WITH WIRED
Web: http://po.st/WiredVideo
Twitter: http://po.st/TwitterWired
Facebook: http://po.st/FacebookWired
Google+: http://po.st/GoogleWired
Instagram: http://po.st/InstagramWired
Magazine: http://po.st/MagazineWired
Newsletter: http://po.st/NewslettersWired
————————–
——–
Facebook: https://www.facebook.com/agingreversed
Tumblr: http://agingreversed.tumblr.com
Twitter: https://twitter.com/Aging_Reversed
Read more
In the far future, tricorders are invented and humanity spends many centuries prospering due in part to their widespread adoption. It’s too early to tell whether we’re on that timeline or a different one, but rest assured that one part of Gene Roddenberry’s quixotic vision for the future has indeed come to pass. Tricorders are coming to the mass market, courtesy of the just-awarded Tricorder XPrize.
The $2.5 million first prize went to Final Frontier Medical Devices, a team of seven including four Trekkie siblings, for their DxtER diagnostic device (below).
Read more
Starving cancer via amino acids looks like a promising approach.
Cutting out certain amino acids — the building blocks of proteins — from the diet of mice slows tumor growth and prolongs survival, according to new research published in Nature.
Researchers at the Cancer Research UK Beatson Institute and the University of Glasgow found that removing two non-essential amino acids — serine and glycine — from the diet of mice slowed the development of lymphoma and intestinal cancer.
The researchers also found that the special diet made some cancer cells more susceptible to chemicals in cells called reactive oxygen species.
Scientists hope they have found a drug to stop all neurodegenerative brain diseases, including dementia. In 2013, a UK Medical Research Council team stopped brain cells dying in an animal for the first time, creating headline news around the world. But the compound used was unsuitable for people, as it caused organ damage. Now two drugs have been found that should have the same protective effect on the brain and are already safely used in people. “It’s really exciting,” said Prof Giovanna Mallucci, from the MRC Toxicology Unit in Leicester. She wants to start human clinical trials on dementia patients soon and expects to know whether the drugs work within two to three years.
Why might they work?
The novel approach is focused on the natural defence mechanisms built into brain cells.
Read more
Facebook’s advanced hardware group is working on technology to let you “hear with your skin.” The technology could be used to help deaf people communicate, but Facebook also envisions it as a way to advance communications for people who can already hear, allowing for such things as a conversation to be automatically translated into another language.
The technology is being developed by Facebook’s Building 8 research group, led by ex-DARPA director and former head of Google’s experimental research group Regina Dugan.
Read more